Press Releases Kinarus Therapeutics Holding AG

Equities

CURE

CH0009115129

Market Closed - Swiss Exchange Other stock markets 10:51:45 2024-05-13 am EDT			5-day change	1st Jan Change
8 ^CHF	0.00%		-17.98%	+346.43%

Apr. 26	Kinarus Therapeutics Completes Merger with Unit, Rebrands as Curatis	MT
Apr. 25	Curatis AG completed the acquisition of Kinarus Therapeutics Holding AG for CHF 18.3 million in a reverse merger transaction.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed	Apr. 26	EQ
Kinarus Therapeutics : Q&A on the Reverse Share Split	Apr. 17	PU
Kinarus Therapeutics : Q&A on the Reverse Share Split” unter Financial News / Corporate News ablegen	Apr. 17	PU
Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination with Curatis AG and Reverse Share Split	Apr. 17	EQ
Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis	Mar. 01	EQ
Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023	Feb. 28	EQ
Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG	Feb. 06	EQ
Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation	Jan. 29	EQ
Kinarus Therapeutics has decided to file for bankruptcy	23-09-25	EQ
Kinarus Therapeutics Group Reports First Half 2023 Financial Results	23-08-30	EQ
Kinarus Therapeutics signed licensing agreement to extend cash for operations	23-08-25	EQ
Kinarus Therapeutics : July 2023 Investor Presentation	23-07-19	PU
Kinarus Therapeutics Announces Personnel Changes	23-07-12	EQ
Kinarus Therapeutics Announces Personnel Change	23-07-12	AQ
Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting	23-06-29	EQ
Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting	23-06-29	AQ
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity	23-06-27	EQ
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity	23-06-27	AQ
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting	23-06-02	EQ
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting	23-06-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Kinarus Therapeutics Holding AG

Equities

CURE

CH0009115129

Press Releases

Filters